Bunnell Incorporated

What Bunnell Incorporated does

Bunnell Incorporated is a privately held specialty medical device company headquartered in North Salt Lake, Utah, that has focused on high-frequency jet ventilation (HFJV) for neonatal and pediatric respiratory care since 1988. The company's commercial offering centers on the LifePulse line of jet ventilators — currently the LifePulse 204 as the flagship, with the LifePulse 203 under an obsolescence notification issued in January 2024 — supported by proprietary HFJV disposables and accessories required for ventilator operation. Underlying technology is mechanical/pneumatic HFJV, designed to deliver gentle, high-frequency ventilation for critically ill infants suffering from conditions such as pulmonary interstitial emphysema (PIE), respiratory distress syndrome (RDS) complicated by pulmonary air leaks, hypoxemic respiratory failure, congenital diaphragmatic hernia, and post-cardiac-surgery recovery.

Bunnell generates revenue through direct enterprise sales of capital equipment and consumables to hospitals with neonatal intensive care units (NICUs) and pediatric intensive care units. The company operates with a dedicated clinical team for sales and customer support, provides a 24-hour HFJV support line, and offers clinical training, free trials, and free CRCE-accredited education. In 2025 the company extended its footprint with the Bunnell mobile application (iOS and Android) consolidating instructional content, manuals, and hotline access. No pricing is publicly disclosed. Marketing relies primarily on clinical education and a library of 30-plus peer-reviewed publications rather than traditional advertising.

The company holds FDA-cleared indications for its HFJV devices and MDSAP certification (MDSAP-235428.260622) covering its quality management system. Bunnell operates as an independent private company with no disclosed venture capital or private equity funding rounds, no parent company, and no subsidiaries identified in available source material. Recent activity includes a September 2025 medical device correction notice (issued by partner NOxBox Ltd) regarding dosing fluctuations when the NOxBOXi nitric oxide delivery system is used with LifePulse ventilators, with three serious injuries reported as of August 28, 2025.

Name

Bunnell Incorporated

Legal name

Bunnell Incorporated

Website

https://bunl.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

51–100 employees

Short description

Bunnell Incorporated is a privately held specialty medical device company that designs, manufactures, and sells LifePulse high-frequency jet ventilators and proprietary disposables to hospital neonatal intensive care units for respiratory support of critically ill infants.

Ownership category

akta.pro rank

Product category

Neonatal Ventilation Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

akta.pro secondary industry

Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK)

Keywords

• Neonatal ventilators
• High-frequency jet ventilation
• Infant respiratory care
• Medical device manufacturing
• NICU equipment

Headquarters

HQ city

Salt Lake City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Bunnell generates revenue through the sale of high-frequency jet ventilators (LifePulse 204 and 203) and related disposables & accessories. The company also provides clinical training and support services as part of their commercial offering.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Bunnell Incorporated designs, manufactures, and sells high-frequency jet ventilators (LifePulse 204 and LifePulse 203) for neonatal and infant respiratory care, along with supporting HFJV disposables and accessories. The company also delivers clinical education, training, and 24-hour technical support for hospitals and NICUs using its LifePulse ventilator platform.

Product overview

Bunnell Incorporated specializes in high-frequency jet ventilation (HFJV) technology for neonatal and infant respiratory care. The product portfolio centers on the LifePulse High-Frequency Jet Ventilator line, currently featuring the LifePulse 204 as the primary offering and the LifePulse 203 under obsolescence notification. Supporting products include HFJV disposables and accessories, plus the Bunnell App for clinical education. The company has served NICU patients since 1988, providing both medical devices and comprehensive training resources for healthcare providers.

Differentiator

Problem solved

Functional benefit

Brands

• LifePulse: LifePulse High-Frequency Jet Ventilator product line including Model 203 and Model 204 jet ventilators for neonatal respiratory care.

Products and services

• LifePulse 204 High-Frequency Jet Ventilator Bunnell's current flagship High-Frequency Jet Ventilator that provides superior physiologic impacts and unique therapeutic flexibility for gentle infant ventilation. Indicated for neonatal and pediatric respiratory support, including treatment of pulmonary interstitial emphysema (PIE), respiratory distress syndrome (RDS) complicated by pulmonary air leaks, and hypoxemic refractory respiratory failure. Sold to hospitals with NICUs and pediatric intensive care units.
• LifePulse 203 High-Frequency Jet Ventilator Legacy high-frequency jet ventilator model from Bunnell used for neonatal respiratory care. The product was placed under an obsolescence notification announced in January 2024, marking the Model 203 as a legacy offering relative to the current LifePulse 204.
• HFJV Disposables & Accessories Consumable and accessory products supporting high-frequency jet ventilation therapy, including the components required to operate the LifePulse ventilator. Sold to hospitals and NICUs as the recurring-use supplies for ongoing LifePulse treatments.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Others

• NOxBox Ltd: NOxBox manufactures the NOxBOXi nitric oxide delivery system, which is used alongside ventilators in NICUs and is the subject of the September 2025 FDA correction referencing interaction with Bunnell's LifePulse. It is an adjacent ecosystem participant rather than a competitor.

Direct peers

• Drägerwerk: Dräger is a leading manufacturer of neonatal and pediatric ventilators used in NICUs worldwide. It directly competes with Bunnell's LifePulse by offering conventional and high-frequency ventilation platforms to the same hospital customer base.
• Hamilton Medical: Hamilton Medical produces high-end ICU and neonatal ventilators, including high-frequency ventilation capabilities. It competes with Bunnell for NICU ventilator purchasing decisions across many of the same hospital systems.
• SLE Ltd: SLE is a UK-based specialist in neonatal ventilation equipment with a long history of serving NICUs. As a niche-focused neonatal ventilator company, it is one of the closest direct comparables to Bunnell in terms of customer base and product focus.

Broad incumbents

• GE HealthCare: GE HealthCare manufactures a broad portfolio of ICU and neonatal ventilators serving NICUs globally. It is a large incumbent competing for the same hospital respiratory-care budgets as Bunnell, although without a dedicated HFJV specialty product.
• Getinge (Maquet): Getinge, through its Maquet brand, is a major provider of neonatal and ICU ventilation solutions for hospitals globally. It offers overlapping respiratory care products to the same hospital customers as Bunnell.
• Medtronic: Medtronic (via the legacy Covidien/Puritan Bennett portfolio) manufactures ICU and transport ventilators used in hospitals. As a large incumbent respiratory care company, it competes for the same NICU and ICU capital equipment budgets as Bunnell.
• Vyaire Medical: Vyaire Medical is a respiratory care company producing ventilators and related consumables for hospitals. It serves overlapping NICU and ICU customers with broader respiratory product portfolios.
• Mindray: Mindray is a major medical device manufacturer with a portfolio that includes ICU and neonatal ventilators. It competes on price and breadth with specialized NICU-focused players like Bunnell, particularly in international markets.

Emerging players

• Inspiration Healthcare: Inspiration Healthcare specializes in neonatal intensive care medical devices, including neonatal ventilators. As a smaller specialty player focused on the NICU market, it is comparable to Bunnell in target customer and product category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bunnell-inc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bunnell Incorporated